Cite
HARVARD Citation
Bailly, B. et al. (2022). Persistent Coronavirus Disease 2019 (COVID-19) in an Immunocompromised Host Treated by Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)-Specific Monoclonal Antibodies. Clinical infectious diseases. pp. 1706-1707. [Online].